NEW YORK CITY — Johnson & Johnson Innovation LLC today announced the opening of JLABS @ NYC. The 30,000-square foot facility, located at the New York Genome Center in the heart of SoHo, is a collaboration between Johnson & Johnson Innovation, New York State and the New York Genome Center. JLABS @ NYC can accommodate up to 30 biotech, pharmaceutical, medical device, consumer and...
from EMS via xlomafota13 on Inoreader https://ift.tt/2ut6bmv
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Note: Page numbers of article titles are in boldface type. from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2dbgxvK
-
Note: Page numbers of article titles are in boldface type. from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2gDH2gG
-
IRVINE, Calif. — In an effort to help firefighters cover the high cost of cancer treatment as a result of the occupational risk of experienc...
-
JAMA Otolaryngology Author Interview: Tinnitus Retraining Therapy vs Standard of Care and Tinnitus-Related Quality of LifeVIEWPOINTThe Searc...
-
Objective: The objective of this article is to provide a summary of the perceptions of healthcare providers and family members toward their ...
-
Sonication of removed implants improves microbiological diagnosis of postoperative spinal infectionsAbstract Purpose In total joint replacement, culturing of the sonication fluid of removed implants has proven to be more sensitive than ...
-
Note: Page numbers of article titles are in boldface type. from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2aggaBB
-
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182, 64 Journals 1aky08-3m5n7.htmlInternati...
-
Objectives: The aim of this study was to identify the impact of antifungal prevention in critically ill immunocompetent adult patients on mo...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου